Scientists have long worked to better understand the immunological responses of the human body throughout various diseases, such as cancer and inflammatory diseases.
An approved medication for the treatment of psoriasis is now starting a significant clinical investigation. Patients who have just received a type 1 diabetes diagnosis will test the medication. According to the theory, the medication might maintain the patient's remaining capacity to produce
Scientists have long worked to better understand the immunological responses of the human body throughout various diseases, such as cancer and inflammatory diseases.
For a long time, researchers have worked to understand the immune reactions that take place in the human body during various illnesses, such as cancer and inflammatory disorders.
A syndrome known as immunological "exhaustion" occurs when the immune system, particularly T cells, are severely weakened by cancer and severe viral infections. Overcoming immunological exhaustion is a key goal in the development of new drugs for serious viral infections or cancer.
The immune system, including T cells, is known to be compromised by severe viral infections and cancer, a condition known as immunological 'exhaustion'. The development of novel medicines for cancer or severe viral infections has a major focus on overcoming immunological fatigue.
The regulation of inflammation has been better understood thanks to research from Trinity College Dublin scientists. Recent research has revealed that a crucial immunological alarm protein that was previously thought to slow down the immune response really has the opposite effect.
Researchers suggested cerebrospinal fluid (CSF) that circulates inside of and around your brain and spinal cord, your three-pound brain doesn't feel particularly heavy. This fluid-filled space between your brain and skull shields it from a blow to the head and saturates it with nutrition.
Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism can be neutralized.
Washington [US], October 4 (ANI): The bacterium that causes tuberculosis has a cousin you've never heard of: MAC. This bacterial complex is everywhere, but most people never show symptoms. Yet some people get very, very sick. Researchers have now uncovered an immunologic defect that could ex
Okinawa [Japan], September 9 (ANI): The Tob gene, which was initially discovered in Prof. Tadashi Yamamoto's old group in Japan in 1996, is well known for its connection to cancer. Previous studies have shown that it also plays a role in controlling the cell cycle and the immunological respo
Heidelberg [Germany], August 21 (ANI): Researchers from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Hebrew University in Jerusalem have discovered the cell of origin of mixed liver/biliary duct carcinomas, a rare type of liver cancer, in mice. Interleuk